# Study to Determine Efficacy & Safety of a Low Concentration Estriol (0.005%) in Postmenopausal Vaginal Atrophy.

> **NCT04574999** · PHASE3 · COMPLETED · sponsor: **Italfarmaco S.A** · enrollment: 167 (actual)

## Conditions studied

- Vaginal Atrophy

## Interventions

- **DRUG:** Estriol
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04574999
- **Lead sponsor:** Italfarmaco S.A
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01-25
- **Primary completion:** 2009-02-23
- **Final completion:** 2009-02-23
- **Target enrollment:** 167 (ACTUAL)
- **Last updated:** 2020-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04574999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04574999, "Study to Determine Efficacy & Safety of a Low Concentration Estriol (0.005%) in Postmenopausal Vaginal Atrophy.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04574999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*